Blood Screening Market Share, Growth, Industry Segmentation, Analysis and Forecast 2029


Blood Screening Market CAGR is expected to be 8.2% during the forecast period and the market size is expected to reach nearly US$ 4.69 Bn. by 2029.

Blood Screening Market Overview: 

The Blood Screening market study gives a complete picture of the competition, including the market share and company profiles of the key competitors in the global industry. The scope of the research includes a thorough investigation of the Blood Screening Market, as well as the reasons for variations in the industry’s growth in various locations.

Request For Free Sample: 

Blood Screening Market Scope:

This market report makes extensive use of secondary sources, directories, and databases, such as annual reports, press releases, journals, company websites, and other databases, to discover and collect excerpts acceptable for this study

Blood Screening Market Segmentation: 

The blood screening market is divided into segments based on end-user, region, technology, product, and service. Among technology, nucleic acid test (NAT) and enzyme-linked immunosorbent assay (ELISA)accounted for the % share in 2021, nucleic acid test (NAT) are projected to progress at % growth rate in the future due to high sensitivity and specificity for viral nucleic acid.Based on products and service, reagents & kits and enzymes and polymerases products are accounted to hold % shares in the forecast period of 2022-2029. Reagents& kits product are projected to develop at the % growth rate in the coming future due to the rise in blood donations, an increase in the incidence of infectious diseases, and government initiatives.

Request For Free Sample: 

Blood Screening Market Key Players:

The entire method entails an examination of the key market players’ financial reports. Following the assessment of the overall market size, the market was segmented into several segments and sub-segments and validated by key industry professionals such as CEOs, VPs, directors, and marketing executives. The biggest players in the Blood Screening market are as follows:

• Abbott Laboratories
• Grifols
• Roche Diagnostics
• Thermo Fisher Scientific, Inc.
• bioMérieux
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Ortho Clinical Diagnostics, Inc.
• Becton, Dickinson, and Company
• Beckman Coulter, Inc.
• Becton Dickinson and Company
• Grifols
• Danaher Corporation (Beckman Coulter)
• F. Hoffmann-La Roche Ltd.
• Enzo Biochem Inc.
• Meridian Bioscience, Inc.
• BD
• Cepheid
• Immucor, Inc.
• Hologic Inc


Blood Screening Market Regional Analysis:

Individual market influencing elements and changes in market laws that influence present and future market trends are also included in the geographical overview of the Blood Screening market study. Current and future trends are examined in order to assess the entire market potential and uncover profitable trends in order to get a more stable footing. The geographical market assessment is based on the present environment and expected developments.

COVID-19 Impact Analysis on Blood Screening Market:

Due to a break in operations, end-user sectors where Blood Screening are used had a decline in growth from January to May in various countries, including China, Italy, Germany, the United Kingdom, the United States, Spain, France, and India. This resulted in a large drop in the revenues of firms operating in these industries and, as a consequence, in demand for Blood Screening manufacturers, affecting the development of the Blood Screening market in 2020. End-user business demand for Blood Screening has dropped considerably as a result of lockdowns and a rise in COVID-19 incidents throughout the world.

Key Questions Answered in the Blood Screening Market Report are: 

  • Which segment had the largest share in the Blood Screening market in 2021?
  • What is the competitive landscape of the Blood Screening market?
  • Which are the key drivers aiding the Blood Screening market growth?
  • Which region has the maximum share in the Blood Screening market?
  • What will be the CAGR of the Blood Screening market during the forecast period (2022-2027)?